Serotonin 5-HT 3 receptor mediation of pain and anti-nociception: Implications for clinical therapeutics

Pain Physician

Volumn 7, Issue 1, 2004, Pages 141-147

  Giordano, James ^a   Schultea, Thomas ^a  

^a Moody Health Science Center/TCC   (United States)

Author keywords

5 HT 3; Neurotransmitter; Pain; Serotonin; Spinal cord

Indexed keywords

2 METHYLSEROTONIN; 4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; 4 AMINO 5 CHLORO 2,3 DIHYDRO N (2 PYRROLIDINYLMETHYL)BENZOFURAN 7 CARBOXAMIDE; 5 CARBAMOYLTRYPTAMINE; AZASETRON; CLOZAPINE; DOLASETRON MESILATE; GRANISETRON; MIRTAZAPINE; NEUROKININ; ONDANSETRON; PHENYLALANINE; PHENYLBIGUANIDE; QUIPAZINE; SEROTONIN; SEROTONIN 3 RECEPTOR; SEX HORMONE; TROPISETRON; ZACOPRIDE;

ANTINOCICEPTION; BINDING AFFINITY; BINDING SITE; BLOOD BRAIN BARRIER; CALCIUM TRANSPORT; DRUG PENETRATION; DRUG RECEPTOR BINDING; HUMAN; MOLECULAR MECHANICS; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; REVIEW; SEROTONINERGIC SYSTEM; SODIUM CURRENT;

EID: 1042292544     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Cooper JR, Bloom FE, Roth RH. Biochemical basis of neuropharmacology. 7th ed, Oxford Press, New York, 1992.
2. Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors-structure and function at the molecular level. Current Topics Med Chem 2002, 2:507-528.
3. Bradley PB, Engel G., Feniuk W et al. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986; 25:563-576.
4. Hoyer D., Clarke DE, Fozard JR et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Reviews 1994; 46: 157-203.
5. Humphrey PPA, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 1993; 14:233-236.
6. 3 receptor binding sites in rabbit ileum: Comparison with those in rat ileum and rat brain. Neurochem Int 1991; 19:389-396.
7. 3 receptors are membrane ion channels. Nature (London) 1989; 339:706-709.
8. 3 receptors in the periphery. Neuropharmacology 1984; 23: 1473-1486.
9. Zeitz KP, Guy N, Malmberg AB et al. The 5HT subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002; 22:1010-1019.
10. 3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol 1989; 159:157-164.
11. LaPorte AM, Kidd EJ, Verge D et al. Autoradiographic mapping of central 5-HT3 receptors. In: Hamon M (ed.) Central and peripheral 5-HT3 receptors. Academic Press, London, 1992.
12. 3 receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci 2002; 22: 6732-6741.
13. 3B receptor subunit. J Biol Chem 1999; 274:30799-30810.
14. 3 receptor agonist. Eur J Pharmacol 1990; 182:193-197.
15. Mawe GM, Branchek TA, Gershon MD. Peripheral serotonin receptors: Identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci USA 1986; 83:9799-9803.
16. Glennon, M. Binding characteristics of a quaternary salt of serotonin, 5-HTQ. Abstract. Second IUPHAR Satellite Meeting on Serotonin, Basel, Switzerland, 1990; pp42.
17. 3 receptor antagonists. J Neurosci 2002; 22:7389-7397.
18. 3 receptor mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons. J Physiol 2000; 529:373-383.
19. Roychoudhury M, Kulkarni SK. Effects of ondansetron on short-term memory retrieval in mice. Methods Find Exp Clin Pharmacol 1997; 19:43-46.
20. Moore KA, Taylor GE, Weinreich D. Serotonin unmasks functional NK-2 receptors in vagal sensory neurons of the guinea pig. J Physiol (Lond) 1999; 514:111-124.
21. Beubler E, Schigiri-Degen A, Gamse R. Inhibition of 5-hydroxytryptamine- and enterotoxin-induced fluid secretion by 5-HT receptor antagonists in the rat jejunum. Eur Pharmacol 1993; 248:157-165.
22. 3 receptor-induced currents in N1E-115 neurobtastoma cells. Eur J Pharmacol 1988; 151:491-495.
23. Reiser, G. Molecular mechanisms of action induced by 5-HT3 receptors in a neuronal cell line and by 5-HT2 receptors in a glial cell line. In: Fozard JR, Saxena PR (eds). Serotonin: Molecular Biology, Receptors and Functional Effects. Birkhauser Verlag: Basel, 1991.
24. 3 receptor antagonist ICS205930. Life Sci 1988; 43:1441-1449.
25. Giordano J, Sacks SM. Sub-anesthetic doses of bupivacaine or lidocaine increase peripheral ICS-205-930-induced analgesia against inflammatory pain in rats. Eur J Pharmacol 1997; 334: 39-41.
26. Christian HR, Wetzel BH, Behl C et al. Functional antagonism of gonadal steroids at the 5-HT type 3 receptor. Mol Endocrinol 1998; 12:1441-1451.
27. 3 receptor sensitization. Eur J Pharmacol 2003; in press.
28. 3 receptor. J Neurophysiol 1991; 65:630-638.
29. 3 receptor antagonists in three pain tests. Neuropharmacol 1989, 28:431-434.
30. Kuraishi Y, Harada Y, Aratani S, et al. Separate involvement of spinal noradrenergic and serotonergic systems in morphine analgesia: Differences in mechanical and thermal algesic tests. Brain Res 1983, 273: 245-249.
31. Giordano J, Barr GA. Possible role of spinal 5-HT in mu- and kappa-opioid receptor-mediated analgesia in the developing rat. Devel Brain Res 1988, 33:121-127.
32. 3 receptor antagonists attenuate inflammatory pain in rats. Eur J Pharmacol 1989, 170:83-86.
33. Sufka K, Schomburg F, Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 1992; 41:53-56.
34. Doak GJ, Sawynok J. Formalin-induced nociceptive behavior and edema: Involvement of multiple peripheral 5-hydroxy-tryptamine receptor subtypes. Neuroscience 1997; 80:939-949.
35. Rossi GR, Haslett C. Inflammation, cell injury and apoptosis. In: SI Said (ed). Proinflammatory and Anti-inflammatory Peptides. Marcel Dekker, New York, 1998:pp 9-19.
36. 3 receptor antagonists on the writhing response of mice. Gen Pharmacol 1995; 26:1301-1306.
37. 4 receptor antagonism potentiates inhibition of intestinal allodynia by 5-HT3 receptor antagonism in conscious rats. Neurosci Lett 1999; 271:61-64.
38. Inoue A, Hashimoto T, Hide I et al. 5-Hydroxytryptamine-facilitated release of Substance-P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP. J Neurochem 1997; 68:128-133.
39. Martin RF, Jordan LM, Willis WD. Differential projections of cat medullary raphe neurons demonstrated by retrograde labeling following spinal cord lesions. J Comp Neurol 1978; 182: 77-88.
40. 2 receptors in spinal dorsal horn. Life Sci 1998; 62:181-190.
41. Giordano J. Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats. Eur J Pharmacol 1991; 199:233-236.
42. Bardin L, Lavarenne J, Eschalier A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 2000; 86:11-18.
43. Giordano J. Neurobiology of pain. In: R Weiner (ed). Chronic pain: A Guide for Clinicians, (6th ed) CRC Press, Boca Raton, 2002, pp 1089-1100.
44. Kehoe WA. Antidepressants for chronic pain: Selection and dosing considerations. Am J Pain Manage 113; 3:161-165.
45. 3 spinal receptor involvement in acute pain in humans. Anesth Analg 2002; 94:1553-1557.
46. Giordano J, Daleo C, Sacks SM. Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 1998; 354:13-14.
47. Babenko V, Graven-Nielsen T, Svensson P et al. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain 1999; 82:1-8.
48. Ernberg M, Hedenberg-Magnusson B, Alstergren P et al. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci 1999; 65:313-325.
49. Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain 2000; 84:339-346.
50. 3 receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trail in 418 patients. Int J Clin Pharmacol Res 2001; 21:1-13.
51. 3 blockers in the treatment of primary fibromyalgia syndrome: a 10-day open study with tropisetron at a low dose. Mater Med Pol 1996; 28:17-19.
52. Muller W, Stratz T. Results of intravenous administration of tropisetron to fibromyalgia patients. Scand J Rheumatol Suppl 2000; 113:59-62.
53. Haus U, Varga B, Stratz T et al. Oral treatment of fibromyalgia with tropisetron given over 28 days: Influence on functional and vegetative symptoms, psychometric parameters and pain. Scand J Rheumatol 2000; 113:55-58.